Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostatic Neoplasms | 74 | 2024 | 11118 | 3.190 |
Why?
|
Receptors, Androgen | 15 | 2023 | 1079 | 2.290 |
Why?
|
Chromosomes, Human, Pair 8 | 7 | 2010 | 452 | 1.130 |
Why?
|
Androgen Antagonists | 17 | 2024 | 1410 | 0.880 |
Why?
|
Prostate | 10 | 2023 | 1770 | 0.850 |
Why?
|
Polymorphism, Single Nucleotide | 31 | 2024 | 15936 | 0.840 |
Why?
|
Carcinoma, Renal Cell | 14 | 2024 | 3164 | 0.800 |
Why?
|
Germ-Line Mutation | 6 | 2022 | 1858 | 0.750 |
Why?
|
Gene Expression Regulation, Neoplastic | 19 | 2024 | 8547 | 0.740 |
Why?
|
Neoplasms, Hormone-Dependent | 6 | 2015 | 410 | 0.710 |
Why?
|
Prostate-Specific Antigen | 15 | 2024 | 2469 | 0.700 |
Why?
|
Genetic Predisposition to Disease | 29 | 2024 | 17904 | 0.670 |
Why?
|
Telomerase | 1 | 2024 | 745 | 0.630 |
Why?
|
Kidney Neoplasms | 12 | 2024 | 4249 | 0.600 |
Why?
|
Genes, BRCA2 | 2 | 2021 | 601 | 0.490 |
Why?
|
Prostatectomy | 13 | 2024 | 1824 | 0.480 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 3 | 2021 | 164 | 0.470 |
Why?
|
Carboplatin | 1 | 2017 | 794 | 0.460 |
Why?
|
Genome-Wide Association Study | 20 | 2024 | 12690 | 0.420 |
Why?
|
Antineoplastic Agents, Hormonal | 7 | 2021 | 1520 | 0.410 |
Why?
|
Enhancer Elements, Genetic | 7 | 2021 | 1363 | 0.400 |
Why?
|
Epigenomics | 6 | 2024 | 943 | 0.390 |
Why?
|
Male | 105 | 2024 | 360804 | 0.390 |
Why?
|
Watchful Waiting | 1 | 2015 | 491 | 0.380 |
Why?
|
Organic Anion Transporters | 4 | 2017 | 101 | 0.380 |
Why?
|
Prostatic Secretory Proteins | 1 | 2010 | 24 | 0.370 |
Why?
|
Radium | 2 | 2024 | 72 | 0.370 |
Why?
|
Androgens | 7 | 2024 | 1286 | 0.360 |
Why?
|
Quantitative Trait Loci | 8 | 2024 | 2116 | 0.360 |
Why?
|
Nuclear Receptor Coactivators | 1 | 2010 | 61 | 0.350 |
Why?
|
Thyroid Neoplasms | 1 | 2024 | 2332 | 0.350 |
Why?
|
Proto-Oncogene Proteins c-myc | 4 | 2022 | 988 | 0.350 |
Why?
|
Genes, myc | 2 | 2022 | 390 | 0.350 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2010 | 277 | 0.340 |
Why?
|
Adenocarcinoma | 6 | 2021 | 6346 | 0.340 |
Why?
|
Head and Neck Neoplasms | 1 | 2024 | 2895 | 0.330 |
Why?
|
Cell Line, Tumor | 16 | 2022 | 16981 | 0.320 |
Why?
|
Genetic Association Studies | 7 | 2021 | 2735 | 0.310 |
Why?
|
Proto-Oncogene Proteins c-met | 3 | 2020 | 571 | 0.310 |
Why?
|
DNA, Neoplasm | 2 | 2011 | 1745 | 0.310 |
Why?
|
Estrogens, Conjugated (USP) | 2 | 2023 | 276 | 0.310 |
Why?
|
Carcinoma, Neuroendocrine | 2 | 2022 | 339 | 0.290 |
Why?
|
BRCA1 Protein | 4 | 2023 | 1155 | 0.280 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2022 | 2825 | 0.280 |
Why?
|
BRCA2 Protein | 3 | 2023 | 805 | 0.280 |
Why?
|
Humans | 118 | 2024 | 761504 | 0.280 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2024 | 11742 | 0.260 |
Why?
|
DNA Methylation | 6 | 2024 | 4398 | 0.250 |
Why?
|
Melanoma | 2 | 2024 | 5709 | 0.250 |
Why?
|
Neuroendocrine Tumors | 2 | 2022 | 641 | 0.240 |
Why?
|
Alleles | 10 | 2023 | 6863 | 0.240 |
Why?
|
DNA Repair | 4 | 2023 | 2045 | 0.240 |
Why?
|
Neoplasm Metastasis | 9 | 2019 | 4915 | 0.230 |
Why?
|
Genetic Loci | 4 | 2017 | 2632 | 0.230 |
Why?
|
Brachytherapy | 4 | 2019 | 1223 | 0.230 |
Why?
|
Precancerous Conditions | 1 | 2010 | 980 | 0.220 |
Why?
|
Leuprolide | 2 | 2024 | 312 | 0.210 |
Why?
|
Promoter Regions, Genetic | 3 | 2024 | 5789 | 0.210 |
Why?
|
Oncogene Protein p55(v-myc) | 1 | 2021 | 5 | 0.200 |
Why?
|
Epigenesis, Genetic | 5 | 2024 | 3802 | 0.200 |
Why?
|
DNA Repair-Deficiency Disorders | 1 | 2021 | 37 | 0.190 |
Why?
|
Prognosis | 15 | 2022 | 29625 | 0.190 |
Why?
|
Thiohydantoins | 1 | 2021 | 19 | 0.190 |
Why?
|
Disease Progression | 13 | 2021 | 13506 | 0.180 |
Why?
|
Antineoplastic Agents | 6 | 2021 | 13639 | 0.180 |
Why?
|
Chromosome Mapping | 4 | 2020 | 4615 | 0.180 |
Why?
|
Estrogens | 1 | 2007 | 1522 | 0.180 |
Why?
|
Neoplasm Recurrence, Local | 8 | 2024 | 9280 | 0.180 |
Why?
|
Survival Rate | 12 | 2024 | 12725 | 0.170 |
Why?
|
Prednisone | 2 | 2024 | 1563 | 0.170 |
Why?
|
Chromatin | 5 | 2023 | 2960 | 0.170 |
Why?
|
Mediator Complex Subunit 1 | 1 | 2019 | 30 | 0.170 |
Why?
|
Allelic Imbalance | 1 | 2020 | 77 | 0.170 |
Why?
|
Hemibody Irradiation | 1 | 2019 | 4 | 0.170 |
Why?
|
Genetic Counseling | 1 | 2023 | 627 | 0.170 |
Why?
|
Ribonucleoside Diphosphate Reductase | 1 | 2019 | 32 | 0.170 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2022 | 3245 | 0.160 |
Why?
|
Phenylenediamines | 1 | 2019 | 88 | 0.160 |
Why?
|
Aged | 39 | 2024 | 169289 | 0.160 |
Why?
|
Rhabdoid Tumor | 1 | 2021 | 210 | 0.160 |
Why?
|
Mutation | 8 | 2024 | 30052 | 0.160 |
Why?
|
Progesterone Reductase | 1 | 2018 | 14 | 0.160 |
Why?
|
Steroid Isomerases | 1 | 2018 | 19 | 0.160 |
Why?
|
Genotype | 13 | 2019 | 12990 | 0.150 |
Why?
|
Middle Aged | 42 | 2024 | 220895 | 0.150 |
Why?
|
Urogenital Neoplasms | 1 | 2019 | 131 | 0.150 |
Why?
|
Kaplan-Meier Estimate | 7 | 2018 | 6484 | 0.140 |
Why?
|
Biomarkers, Pharmacological | 1 | 2018 | 161 | 0.140 |
Why?
|
Taxoids | 2 | 2017 | 668 | 0.140 |
Why?
|
Cohort Studies | 16 | 2021 | 41487 | 0.140 |
Why?
|
Ubiquitin Thiolesterase | 3 | 2021 | 455 | 0.140 |
Why?
|
Extracellular Matrix Proteins | 1 | 2021 | 829 | 0.140 |
Why?
|
Neoplasm Staging | 8 | 2018 | 11121 | 0.140 |
Why?
|
Neoplasm Invasiveness | 5 | 2017 | 3595 | 0.140 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2020 | 790 | 0.140 |
Why?
|
Transcription Factors | 5 | 2023 | 12128 | 0.130 |
Why?
|
Urologic Neoplasms | 1 | 2019 | 314 | 0.130 |
Why?
|
Inservice Training | 1 | 2018 | 375 | 0.130 |
Why?
|
Drug Administration Schedule | 3 | 2015 | 4853 | 0.130 |
Why?
|
Biological Transport | 2 | 2017 | 2091 | 0.120 |
Why?
|
Neoplasms | 4 | 2023 | 22170 | 0.120 |
Why?
|
Gonadotropin-Releasing Hormone | 3 | 2011 | 1148 | 0.120 |
Why?
|
Tuberculosis, Pulmonary | 2 | 2001 | 832 | 0.120 |
Why?
|
Multienzyme Complexes | 1 | 2018 | 666 | 0.120 |
Why?
|
Orchiectomy | 3 | 2011 | 463 | 0.120 |
Why?
|
Kallikreins | 1 | 2015 | 220 | 0.120 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2015 | 367 | 0.120 |
Why?
|
Germ Cells | 3 | 2023 | 634 | 0.120 |
Why?
|
Cancer Care Facilities | 1 | 2017 | 422 | 0.110 |
Why?
|
Genetic Variation | 4 | 2018 | 6567 | 0.110 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2019 | 736 | 0.110 |
Why?
|
Pneumonectomy | 1 | 2001 | 1119 | 0.110 |
Why?
|
Disease-Free Survival | 4 | 2018 | 6814 | 0.110 |
Why?
|
Inheritance Patterns | 1 | 2016 | 341 | 0.110 |
Why?
|
Video Recording | 1 | 2019 | 966 | 0.110 |
Why?
|
Survival Analysis | 5 | 2021 | 10090 | 0.110 |
Why?
|
RNA Interference | 3 | 2021 | 2831 | 0.110 |
Why?
|
Superoxide Dismutase | 1 | 2016 | 594 | 0.110 |
Why?
|
Aged, 80 and over | 15 | 2024 | 58976 | 0.110 |
Why?
|
Cell Proliferation | 4 | 2019 | 10445 | 0.110 |
Why?
|
Phenylthiohydantoin | 3 | 2020 | 205 | 0.110 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2019 | 782 | 0.110 |
Why?
|
Testosterone | 5 | 2024 | 2472 | 0.100 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2015 | 855 | 0.100 |
Why?
|
Trypsin Inhibitor, Kazal Pancreatic | 1 | 2012 | 30 | 0.100 |
Why?
|
PTEN Phosphohydrolase | 1 | 2018 | 1115 | 0.100 |
Why?
|
Acetylation | 3 | 2023 | 1055 | 0.100 |
Why?
|
Tuberculosis, Multidrug-Resistant | 1 | 2001 | 934 | 0.100 |
Why?
|
Organic Cation Transport Proteins | 1 | 2012 | 61 | 0.100 |
Why?
|
Immunoblotting | 1 | 2015 | 1646 | 0.100 |
Why?
|
Hepatocyte Nuclear Factor 1-beta | 1 | 2012 | 92 | 0.100 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2017 | 5305 | 0.100 |
Why?
|
Combined Modality Therapy | 5 | 2021 | 8529 | 0.100 |
Why?
|
Estradiol Dehydrogenases | 1 | 2011 | 16 | 0.100 |
Why?
|
Pyrophosphatases | 1 | 2012 | 142 | 0.100 |
Why?
|
Organic Anion Transporters, Sodium-Independent | 1 | 2011 | 28 | 0.100 |
Why?
|
Metabolomics | 1 | 2020 | 1659 | 0.090 |
Why?
|
Radiotherapy | 1 | 2018 | 1499 | 0.090 |
Why?
|
Telomere | 1 | 2017 | 943 | 0.090 |
Why?
|
HEK293 Cells | 1 | 2020 | 4278 | 0.090 |
Why?
|
Polymorphism, Genetic | 3 | 2012 | 4243 | 0.090 |
Why?
|
Linkage Disequilibrium | 4 | 2020 | 1998 | 0.090 |
Why?
|
Bone Neoplasms | 2 | 2024 | 2529 | 0.090 |
Why?
|
Protein Binding | 2 | 2015 | 9351 | 0.090 |
Why?
|
Risk Factors | 15 | 2023 | 74206 | 0.090 |
Why?
|
Insulin Resistance | 1 | 2024 | 3963 | 0.090 |
Why?
|
Cell Line | 3 | 2020 | 15601 | 0.090 |
Why?
|
Pyrimidines | 2 | 2019 | 3028 | 0.090 |
Why?
|
Retrospective Studies | 14 | 2022 | 80636 | 0.080 |
Why?
|
Estrogen Receptor beta | 1 | 2010 | 168 | 0.080 |
Why?
|
Colorectal Neoplasms | 1 | 2009 | 6935 | 0.080 |
Why?
|
Nitriles | 3 | 2020 | 971 | 0.080 |
Why?
|
Homeodomain Proteins | 2 | 2015 | 2416 | 0.080 |
Why?
|
Dehydroepiandrosterone Sulfate | 3 | 2015 | 241 | 0.080 |
Why?
|
TCF Transcription Factors | 1 | 2009 | 138 | 0.080 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2009 | 152 | 0.080 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2011 | 550 | 0.080 |
Why?
|
Benzamides | 3 | 2020 | 1370 | 0.080 |
Why?
|
Cluster Analysis | 1 | 2015 | 2707 | 0.080 |
Why?
|
Chemokine CCL2 | 1 | 2010 | 605 | 0.080 |
Why?
|
Tumor Suppressor Proteins | 2 | 2021 | 2803 | 0.070 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2009 | 418 | 0.070 |
Why?
|
Gonadal Steroid Hormones | 1 | 2011 | 702 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2018 | 3492 | 0.070 |
Why?
|
Binding Sites | 1 | 2015 | 6055 | 0.070 |
Why?
|
Follow-Up Studies | 9 | 2021 | 39106 | 0.070 |
Why?
|
RNA, Neoplasm | 1 | 2009 | 750 | 0.070 |
Why?
|
Adult | 19 | 2021 | 221177 | 0.070 |
Why?
|
Estrogen Receptor alpha | 1 | 2010 | 582 | 0.070 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2019 | 3602 | 0.060 |
Why?
|
Genetic Diseases, Inborn | 1 | 2010 | 604 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3201 | 0.060 |
Why?
|
Quality of Life | 3 | 2024 | 13367 | 0.060 |
Why?
|
Treatment Outcome | 10 | 2024 | 64680 | 0.060 |
Why?
|
Genome, Human | 3 | 2019 | 4425 | 0.060 |
Why?
|
Genetic Linkage | 1 | 2010 | 2341 | 0.060 |
Why?
|
DNA Primers | 1 | 2009 | 2819 | 0.060 |
Why?
|
Polymerase Chain Reaction | 2 | 2011 | 6075 | 0.060 |
Why?
|
Health Personnel | 1 | 2018 | 3335 | 0.060 |
Why?
|
Sequence Analysis, DNA | 1 | 2015 | 4740 | 0.060 |
Why?
|
MicroRNAs | 2 | 2011 | 3816 | 0.060 |
Why?
|
Cell Adhesion | 1 | 2010 | 3087 | 0.060 |
Why?
|
Electronic Health Records | 2 | 2018 | 4811 | 0.060 |
Why?
|
Risk | 3 | 2012 | 9610 | 0.060 |
Why?
|
Genomics | 1 | 2019 | 5821 | 0.060 |
Why?
|
Mice, Inbred NOD | 2 | 2019 | 1827 | 0.050 |
Why?
|
Lutetium | 1 | 2023 | 38 | 0.050 |
Why?
|
Heterocyclic Compounds, 1-Ring | 1 | 2023 | 68 | 0.050 |
Why?
|
Female | 19 | 2024 | 392644 | 0.050 |
Why?
|
Marital Status | 1 | 2024 | 426 | 0.050 |
Why?
|
Mendelian Randomization Analysis | 2 | 2019 | 1007 | 0.050 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2024 | 305 | 0.050 |
Why?
|
Prospective Studies | 5 | 2024 | 54425 | 0.050 |
Why?
|
Histones | 3 | 2018 | 2580 | 0.050 |
Why?
|
Sequence Analysis | 1 | 2022 | 240 | 0.050 |
Why?
|
Transcription, Genetic | 2 | 2021 | 7594 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2024 | 586 | 0.050 |
Why?
|
Genealogy and Heraldry | 1 | 2021 | 29 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2018 | 10766 | 0.050 |
Why?
|
Odds Ratio | 3 | 2019 | 9646 | 0.050 |
Why?
|
Nucleotides | 1 | 2023 | 454 | 0.050 |
Why?
|
Dipeptides | 1 | 2023 | 391 | 0.050 |
Why?
|
Nuclear Proteins | 2 | 2013 | 5796 | 0.050 |
Why?
|
Chi-Square Distribution | 2 | 2018 | 3416 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2015 | 12795 | 0.040 |
Why?
|
Propensity Score | 2 | 2018 | 1913 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2010 | 2917 | 0.040 |
Why?
|
RNA, Double-Stranded | 1 | 2021 | 294 | 0.040 |
Why?
|
Genetic Markers | 2 | 2019 | 2601 | 0.040 |
Why?
|
Penetrance | 1 | 2021 | 383 | 0.040 |
Why?
|
Algorithms | 1 | 2020 | 14031 | 0.040 |
Why?
|
Fanconi Anemia | 1 | 2021 | 324 | 0.040 |
Why?
|
Genes, Neoplasm | 1 | 2021 | 370 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2012 | 4936 | 0.040 |
Why?
|
Carcinoma | 1 | 2010 | 2330 | 0.040 |
Why?
|
Phenotype | 4 | 2020 | 16591 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2024 | 4580 | 0.040 |
Why?
|
Preoperative Period | 1 | 2021 | 551 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2021 | 428 | 0.040 |
Why?
|
Epithelial Cells | 1 | 2010 | 3673 | 0.040 |
Why?
|
Risk Assessment | 3 | 2021 | 23995 | 0.040 |
Why?
|
Colonic Neoplasms | 1 | 2010 | 2538 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2021 | 3639 | 0.040 |
Why?
|
Breast Neoplasms | 2 | 2019 | 21012 | 0.040 |
Why?
|
Gene Expression Profiling | 3 | 2021 | 9420 | 0.040 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2021 | 698 | 0.040 |
Why?
|
Lymphocyte Count | 1 | 2019 | 778 | 0.040 |
Why?
|
Massachusetts | 1 | 2010 | 8830 | 0.040 |
Why?
|
Interferons | 1 | 2021 | 706 | 0.040 |
Why?
|
Oncogenes | 1 | 2023 | 1222 | 0.030 |
Why?
|
Europe | 1 | 2024 | 3422 | 0.030 |
Why?
|
Proportional Hazards Models | 3 | 2019 | 12463 | 0.030 |
Why?
|
Radioisotopes | 1 | 2018 | 499 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2018 | 550 | 0.030 |
Why?
|
Immunotherapy | 1 | 2012 | 4652 | 0.030 |
Why?
|
DNA-Binding Proteins | 3 | 2023 | 9606 | 0.030 |
Why?
|
Indazoles | 1 | 2018 | 304 | 0.030 |
Why?
|
Obesity | 1 | 2019 | 12947 | 0.030 |
Why?
|
Immunity | 1 | 2022 | 996 | 0.030 |
Why?
|
United States | 5 | 2024 | 72334 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2024 | 22176 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2023 | 1616 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 1136 | 0.030 |
Why?
|
Income | 1 | 2024 | 1877 | 0.030 |
Why?
|
Efficiency | 1 | 2018 | 476 | 0.030 |
Why?
|
Gene Amplification | 1 | 2019 | 1089 | 0.030 |
Why?
|
Body Composition | 1 | 2024 | 2426 | 0.030 |
Why?
|
Signal Transduction | 4 | 2021 | 23445 | 0.030 |
Why?
|
Haplotypes | 2 | 2011 | 2713 | 0.030 |
Why?
|
Multivariate Analysis | 3 | 2015 | 12059 | 0.030 |
Why?
|
Atlases as Topic | 1 | 2016 | 248 | 0.030 |
Why?
|
Histone Code | 1 | 2015 | 158 | 0.030 |
Why?
|
Pelvis | 1 | 2019 | 732 | 0.030 |
Why?
|
Bone Remodeling | 1 | 2018 | 581 | 0.030 |
Why?
|
Language | 1 | 2024 | 1540 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2018 | 2469 | 0.030 |
Why?
|
Self Efficacy | 1 | 2018 | 638 | 0.030 |
Why?
|
Respiratory Mechanics | 1 | 1998 | 699 | 0.030 |
Why?
|
Social Support | 1 | 2024 | 2171 | 0.030 |
Why?
|
Binding, Competitive | 1 | 2015 | 1141 | 0.030 |
Why?
|
Mice, SCID | 1 | 2019 | 2626 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2022 | 1902 | 0.030 |
Why?
|
Nephrectomy | 2 | 2012 | 937 | 0.030 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2015 | 297 | 0.030 |
Why?
|
Hematopoiesis | 1 | 2023 | 2049 | 0.030 |
Why?
|
Up-Regulation | 1 | 2022 | 4124 | 0.030 |
Why?
|
Drug Synergism | 1 | 2017 | 1755 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2019 | 1756 | 0.030 |
Why?
|
Introns | 1 | 2015 | 981 | 0.030 |
Why?
|
Molecular Sequence Annotation | 1 | 2015 | 522 | 0.030 |
Why?
|
Lymphatic Metastasis | 2 | 2015 | 2915 | 0.030 |
Why?
|
Heterozygote | 1 | 2019 | 2787 | 0.030 |
Why?
|
Exercise Tolerance | 1 | 1998 | 836 | 0.030 |
Why?
|
Pulmonary Emphysema | 1 | 1998 | 684 | 0.030 |
Why?
|
Benchmarking | 1 | 2018 | 1045 | 0.020 |
Why?
|
Adolescent | 4 | 2021 | 88319 | 0.020 |
Why?
|
Kinetics | 1 | 2019 | 6374 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2019 | 2208 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2021 | 6310 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2019 | 2455 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2023 | 3396 | 0.020 |
Why?
|
Mice | 4 | 2019 | 81525 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2020 | 2691 | 0.020 |
Why?
|
Program Evaluation | 1 | 2018 | 2495 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2018 | 3514 | 0.020 |
Why?
|
Animals | 6 | 2021 | 168459 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1893 | 0.020 |
Why?
|
Leukocytes | 1 | 2017 | 2026 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2018 | 2161 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2024 | 4948 | 0.020 |
Why?
|
Young Adult | 3 | 2021 | 59243 | 0.020 |
Why?
|
Liver | 1 | 2024 | 7529 | 0.020 |
Why?
|
Regression Analysis | 2 | 2015 | 6343 | 0.020 |
Why?
|
Sulfonamides | 1 | 2018 | 1978 | 0.020 |
Why?
|
Phosphorylation | 1 | 2019 | 8320 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4575 | 0.020 |
Why?
|
Cell Survival | 1 | 2018 | 5791 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2010 | 368 | 0.020 |
Why?
|
Pain | 1 | 2023 | 5073 | 0.020 |
Why?
|
Child, Preschool | 2 | 2021 | 42230 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2015 | 15266 | 0.020 |
Why?
|
Locomotion | 1 | 1990 | 388 | 0.020 |
Why?
|
Registries | 1 | 2024 | 8224 | 0.020 |
Why?
|
Lipids | 1 | 2019 | 3341 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2018 | 5247 | 0.020 |
Why?
|
Foreign Bodies | 1 | 1972 | 402 | 0.020 |
Why?
|
Transfection | 1 | 2015 | 5774 | 0.020 |
Why?
|
Cause of Death | 1 | 2018 | 3683 | 0.020 |
Why?
|
Computational Biology | 1 | 2019 | 3518 | 0.020 |
Why?
|
Neutrophils | 1 | 2019 | 3767 | 0.020 |
Why?
|
Metabolic Networks and Pathways | 1 | 2011 | 789 | 0.020 |
Why?
|
Lymphography | 2 | 1966 | 188 | 0.020 |
Why?
|
Internet | 1 | 2019 | 3092 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2024 | 11528 | 0.020 |
Why?
|
Lung | 2 | 1998 | 10000 | 0.020 |
Why?
|
Chyle | 1 | 1966 | 19 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2023 | 14605 | 0.020 |
Why?
|
Urinary Fistula | 1 | 1966 | 42 | 0.020 |
Why?
|
Medical Oncology | 1 | 2018 | 2321 | 0.020 |
Why?
|
Computer Simulation | 1 | 2020 | 6240 | 0.020 |
Why?
|
Genetics, Population | 1 | 2010 | 937 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10552 | 0.020 |
Why?
|
Organ Specificity | 1 | 2010 | 1967 | 0.020 |
Why?
|
Extremities | 1 | 1990 | 867 | 0.020 |
Why?
|
Time Factors | 2 | 2017 | 39967 | 0.010 |
Why?
|
Lymphatic System | 1 | 1966 | 254 | 0.010 |
Why?
|
Fistula | 1 | 1966 | 212 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2022 | 11903 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2018 | 3889 | 0.010 |
Why?
|
Corpus Striatum | 1 | 1990 | 1235 | 0.010 |
Why?
|
Blood Glucose | 1 | 2019 | 6391 | 0.010 |
Why?
|
Insulin | 1 | 2019 | 6596 | 0.010 |
Why?
|
Mepivacaine | 1 | 1963 | 8 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13255 | 0.010 |
Why?
|
Podiatry | 1 | 1963 | 28 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2019 | 18965 | 0.010 |
Why?
|
Blood Pressure | 1 | 2019 | 8481 | 0.010 |
Why?
|
Child | 2 | 2021 | 80153 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2011 | 4111 | 0.010 |
Why?
|
Models, Biological | 1 | 2018 | 9469 | 0.010 |
Why?
|
Models, Genetic | 1 | 2012 | 3442 | 0.010 |
Why?
|
Lung Diseases | 1 | 1972 | 1909 | 0.010 |
Why?
|
Anesthesia, Local | 1 | 1963 | 277 | 0.010 |
Why?
|
Aortic Aneurysm | 1 | 1966 | 648 | 0.010 |
Why?
|
Body Mass Index | 1 | 2019 | 12953 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2010 | 3448 | 0.010 |
Why?
|
Infant | 1 | 2001 | 36192 | 0.010 |
Why?
|
Maximal Voluntary Ventilation | 1 | 1998 | 14 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2001 | 15631 | 0.010 |
Why?
|
Pulmonary Diffusing Capacity | 1 | 1998 | 94 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2010 | 4511 | 0.010 |
Why?
|
Lymph Node Excision | 1 | 1964 | 1271 | 0.010 |
Why?
|
Respiratory Muscles | 1 | 1998 | 142 | 0.010 |
Why?
|
Testicular Neoplasms | 1 | 1964 | 799 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20098 | 0.010 |
Why?
|
Lung Volume Measurements | 1 | 1998 | 375 | 0.010 |
Why?
|
Anesthetics, Local | 1 | 1963 | 997 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2019 | 12148 | 0.010 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1964 | 2020 | 0.010 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1964 | 2223 | 0.010 |
Why?
|
Neurons | 1 | 1990 | 9463 | 0.010 |
Why?
|
Incidence | 1 | 2009 | 21353 | 0.010 |
Why?
|
Exercise Test | 1 | 1998 | 2127 | 0.010 |
Why?
|
Skin Physiological Phenomena | 1 | 1990 | 188 | 0.010 |
Why?
|
Electrodes | 1 | 1990 | 614 | 0.000 |
Why?
|
Electrophysiology | 1 | 1990 | 1262 | 0.000 |
Why?
|
Angiocardiography | 1 | 1966 | 149 | 0.000 |
Why?
|
Electric Stimulation | 1 | 1990 | 1736 | 0.000 |
Why?
|
Urine | 1 | 1966 | 362 | 0.000 |
Why?
|
Diagnostic Errors | 1 | 1972 | 1265 | 0.000 |
Why?
|
Radiography | 1 | 1972 | 6965 | 0.000 |
Why?
|
Statistics as Topic | 1 | 1966 | 2358 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1972 | 12974 | 0.000 |
Why?
|
Rats | 1 | 1990 | 23742 | 0.000 |
Why?
|